# Oral Dosage Form New Animal Drugs; Lufenuron Tablets
> **Food and Drug Administration** · Final rule. · Published 1998-10-02 · Effective 1998-10-02 · 63 FR 52968
## Document
- **Document number:** 98-26423
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 63 FR 52968
- **CFR reference:** 21 CFR 520
- **Publication date:** 1998-10-02
- **Effective date:** 1998-10-02
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The supplemental NADA provides for revising the specifications and conditions of use of lufenuron tablets for dogs and cats for control of flea populations.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1998/10/02/98-26423/oral-dosage-form-new-animal-drugs-lufenuron-tablets)
---
*AI Analytics · CC0 1.0*